NANO . MONOCLONAL . ANTIBODY

focusing on the development of next generation radiopharmaceuticals for cancer precision medicine

NanoMab
a little about...

NanoMab

NanoMab Technology Limited is a privately held biopharmaceutical company focusing on the development of next generation radiopharmaceuticals for cancer precision medicine to be used in conjunction with the established network of PET facilities all over the world. Our goal is to develop a pipeline of theranostic couple camelid antibodies with our proprietary camelid antibodies platform to address the unmet diagnostic and medical need for cancer patients in the world.